Artelo Biosciences, Inc.(ARTL)
Biotechnology
Oncology Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2022-08-12 | Gorgas Gregory D. Pres, CEO, CFO, Treas & Secr | Purchase | +1,200 | +0.38%315,068 | $4.00 | $4,800 | View SEC filing | |
| 2022-08-11 | Gorgas Gregory D. Pres, CEO, CFO, Treas & Secr | Purchase | +1,200 | +0.38%313,868 | $4.03 | $4,836 | View SEC filing | |
| 2021-04-20 | Gorgas Gregory D. Pres, CEO, CFO, Treas & Secr | Purchase | +8,500 | +2.79%312,668 | $1.15 | $9,809 | View SEC filing | |
| 2020-05-19 | Gorgas Gregory D. Pres, CEO, CFO, Treas & Secr | Purchase | +5,800 | +2.25%263,776 | $0.90 | $5,232 | View SEC filing | |
| 2020-05-04 | MATSUI CONNIE Director | Purchase | +41,667 | +277.78%56,667 | $1.20 | $50,000 | View SEC filing | |
| 2020-05-04 | Gorgas Gregory D. Pres, CEO, CFO, Treas & Secr | Purchase | +4,167 | +1.64%257,976 | $1.20 | $5,000 | View SEC filing | |
| 2019-11-05 | Gorgas Gregory D. Pres, CEO, CFO, Treas & Secr | Purchase | +2,400 | +0.95%253,809 | $2.21 | $5,304 | View SEC filing | |
| 2019-11-01 | Gorgas Gregory D. Pres, CEO, CFO, Treas & Secr | Purchase | +7,600 | +3.12%251,409 | $2.07 | $15,763 | View SEC filing | |
| 2019-10-17 | Gorgas Gregory D. Pres, CEO, CFO, Treas & Secr | Purchase | +2,600 | +1.08%243,809 | $2.05 | $5,333 | View SEC filing | |
| 2019-10-11 | Gorgas Gregory D. Pres, CEO, CFO, Treas & Secr | Purchase | +2,700 | +1.13%241,209 | $1.96 | $5,296 | View SEC filing |
1-10 of 10